Get startedLog in
    Picture of Harvard Apparatus Regenerative Technology logo

    HRGN — Harvard Apparatus Regenerative Technology News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    All News

    Brief: Biostage CEO provides mid-year update to shareholders

    Picture of Harvard Apparatus Regenerative Technology logoHarvard Apparatus Regenerative Technology
    21/06/2016 17:21
    June 21 (Reuters) - Biostage Inc  BSTG.O  :     
    * Biostage CEO provides mid-year update to shareholders 
    * Now have capital to get through a number of milestones in 
2016 including filing of IND; expect to move into human clinical 
trials in 2017 
    * Remain on schedule to file IND for Cellspan Esophageal 
implant by end of 2016 to advance into human clinical trials 
    * Expect to follow first esophageal product candidate with 
additional products to address life-threatening conditions of 
bronchus, trachea 
 
Source text for Eikon:  ID:nPn4NKWqNa  
Further company coverage:  BSTG.O  
 
 (Bengaluru Newsroom: +1 646 223 8780)

    Recent news on Harvard Apparatus Regenerative Technology

    See all news